Lactating women should discuss risks and benefits of COVID-19 vaccination, says ABM

The Academy of Breastfeeding Medicine (ABM) does not recommend cessation of breastfeeding for individuals who are vaccinated against COVID-19.

In a new statement, the ABM suggests that lactating women discuss the risks and benefits of vaccination with their health care provider, within the context of their risk of contracting COVID-19 and of developing severe disease, according to the peer-reviewed journal Breastfeeding Medicine. Click here to read the ABM statement now.

This is a challenging topic because the vaccine trials excluded lactating women. Thus, there are no clinical data regarding the safety of the Pfizer/BioNtech or the Moderna vaccine in nursing mothers. According to the ABM statement, "there is little biological plausibility that the vaccine will cause harm, and antibodies to SARS-CoV-2 [the virus that causes COVID-19] in milk may protect the breastfeeding child."

"Without clinical data, the Academy of Breastfeeding Medicine relied on biological plausibility and expert opinion to craft a statement on considerations for mRNA COVID-19 vaccines in lactation," says Alison Stuebe, MD, President of ABM.

"The available information is reassuring; however, pregnant and lactating people deserve better than plausibility to guide medical decisions. Henceforward, phase 3 clinical trials should routinely include pregnant and lactating participants. It's time to protect pregnant and breastfeeding individuals through research, not from research."

Source:
Journal reference:

Stuebe, A., et al. (2020) President's Corner: Introduction to ABM's Statement on Considerations for COVID-19 Vaccination in Lactation. Breastfeeding Medicine. doi.org/10.1089/bfm.2020.29171.ams.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials